23 May 2013
Keywords: Ligand, AstraZeneca, MEDI-528, IL9 antibody program
Article | 24 May 2010
San Diego, USA-based Ligand Pharmaceuticals says that it has bought from the Genaera Liquidating Trust certain intellectual property and interests ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 May 2010
25 May 2010
22 May 2013
© 2013 thepharmaletter.com